{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:46:02Z","timestamp":1788561962851,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12286-9","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:09:57Z","timestamp":1783516197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paclitaxel and B7-H6 knockdown inhibit HepG2 hepatocellular carcinoma cell viability and migration, while enhancing apoptosis and cell cycle arrest"],"prefix":"10.1007","volume":"53","author":[{"given":"Shiva","family":"Alipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Safdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Baghbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Karamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Mehdizadehfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-6795","authenticated-orcid":false,"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"26","key":"12286_CR1","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.4254\/wjh.v7.i26.2648","volume":"7","author":"LP Waller","year":"2015","unstructured":"Waller LP, Deshpande V, Pyrsopoulos N (2015) Hepatocellular carcinoma: A comprehensive review. World J Hepatol 7(26):2648","journal-title":"World J Hepatol"},{"key":"12286_CR2","first-page":"30030","volume":"15","author":"S Sohrabi","year":"2024","unstructured":"Sohrabi S, Alipour S, Ghahramanipour Z, Masoumi J, Baradaran B (2024) STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis. BioImpacts: BI 15:30030","journal-title":"BioImpacts: BI"},{"key":"12286_CR3","doi-asserted-by":"publisher","first-page":"122686","DOI":"10.1016\/j.lfs.2024.122686","volume":"348","author":"S Alipour","year":"2024","unstructured":"Alipour S, Mardi A, Shajari N, Kazemi T, Sadeghi MR, Heris JA et al (2024) Unmasking the NLRP3 inflammasome in dendritic cells as a potential therapeutic target for autoimmunity, cancer, and infectious conditions. Life Sci 348:122686","journal-title":"Life Sci"},{"issue":"2","key":"12286_CR4","doi-asserted-by":"publisher","first-page":"HEP08","DOI":"10.2217\/hep-2018-0002","volume":"5","author":"R Kumari","year":"2018","unstructured":"Kumari R, Sahu MK, Tripathy A, Uthansingh K, Behera M (2018) Hepatocellular carcinoma treatment: hurdles, advances and prospects. Hepatic Oncol 5(2):HEP08","journal-title":"Hepatic Oncol"},{"issue":"3","key":"12286_CR5","doi-asserted-by":"publisher","first-page":"111290","DOI":"10.1016\/j.humimm.2025.111290","volume":"86","author":"S Sohrabi","year":"2025","unstructured":"Sohrabi S, Masoumi J, Naseri B, Baghbani E, Kazemi T, Maleki LA et al (2025) Pyrimethamine treatment in breast cancer lysate-loaded dendritic cells promotes autologous T cells\u2019 anti-tumor responses in vitro. Hum Immunol 86(3):111290","journal-title":"Hum Immunol"},{"issue":"3","key":"12286_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/08830185.2023.2274576","volume":"43","author":"S Sohrabi","year":"2024","unstructured":"Sohrabi S, Masoumi J, Naseri B, Ghorbaninezhad F, Alipour S, Kazemi T et al (2024) STATs signaling pathways in dendritic cells: As potential therapeutic targets? Int Rev Immunol 43(3):138\u2013159","journal-title":"Int Rev Immunol"},{"issue":"1","key":"12286_CR7","doi-asserted-by":"publisher","first-page":"e18761429310703","DOI":"10.2174\/0118761429310703240823045808","volume":"17","author":"B Sensi","year":"2024","unstructured":"Sensi B, Angelico R, Toti L, Conte LE, Coppola A, Tisone G et al (2024) Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation. Curr Mol Pharmacol 17(1):e18761429310703","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"12286_CR8","doi-asserted-by":"publisher","first-page":"7550","DOI":"10.1038\/s41598-021-87216-9","volume":"11","author":"B Cherif","year":"2021","unstructured":"Cherif B, Triki H, Charfi S, Bouzidi L, Kridis WB, Khanfir A et al (2021) Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer. Sci Rep 11(1):7550","journal-title":"Sci Rep"},{"key":"12286_CR9","doi-asserted-by":"publisher","first-page":"120709","DOI":"10.1016\/j.lfs.2022.120709","volume":"304","author":"A Mohammadi","year":"2022","unstructured":"Mohammadi A, Najafi S, Amini M, Mansoori B, Baghbanzadeh A, Hoheisel JD et al (2022) The potential of B7-H6 as a therapeutic target in cancer immunotherapy. Life Sci 304:120709","journal-title":"Life Sci"},{"issue":"12","key":"12286_CR10","doi-asserted-by":"publisher","first-page":"2300142","DOI":"10.1002\/adbi.202300142","volume":"7","author":"Z Ghahramanipour","year":"2023","unstructured":"Ghahramanipour Z, Alipour S, Masoumi J, Rostamlou A, Hatami-Sadr A, Heris JA et al (2023) Regulation of dendritic cell functions by vitamins as promising therapeutic strategy for immune system disorders. Adv Biology 7(12):2300142","journal-title":"Adv Biology"},{"issue":"19","key":"12286_CR11","doi-asserted-by":"publisher","first-page":"10326","DOI":"10.3390\/ijms251910326","volume":"25","author":"S Lee","year":"2024","unstructured":"Lee S, Kim JH, Jang I-H, Jo S, Lee SY, Oh S-C et al (2024) Harnessing B7-H6 for anticancer immunotherapy: expression, pathways, and therapeutic strategies. Int J Mol Sci 25(19):10326","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12286_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12935-018-0627-7","volume":"18","author":"L Chen","year":"2018","unstructured":"Chen L, Feng J, Xu B, Zhou Y, Zheng X, Wu C et al (2018) Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance. Cancer Cell Int 18(1):126","journal-title":"Cancer Cell Int"},{"issue":"3","key":"12286_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/apm.13099","volume":"129","author":"H Qiu","year":"2021","unstructured":"Qiu H, Gao S, Sun Z, Wang J (2021) Dual role of B7-H6 as a novel prognostic marker in hepatocellular carcinoma. Apmis 129(3):105\u2013117","journal-title":"Apmis"},{"issue":"6372","key":"12286_CR14","doi-asserted-by":"publisher","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","volume":"359","author":"CE Dunbar","year":"2018","unstructured":"Dunbar CE, High KA, Joung JK, Kohn DB, Ozawa K, Sadelain M (2018) Gene therapy comes of age. Science 359(6372):eaan4672","journal-title":"Science"},{"issue":"1","key":"12286_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","volume":"25","author":"R Mu","year":"2024","unstructured":"Mu R, Chang M, Feng C, Cui Y, Li T, Liu C et al (2024) Analysis of the expression of PRDX6 in patients with hepatocellular carcinoma and its effect on the phenotype of hepatocellular carcinoma cells. Curr Genom 25(1):2\u201311","journal-title":"Curr Genom"},{"issue":"7","key":"12286_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2174\/0115665240303370240530120450","volume":"25","author":"M Shahverdi","year":"2025","unstructured":"Shahverdi M, Alamdari-Palangi V, Alipour S, Jolfayi AG, Masoumi J, Aghebati-Maleki L et al (2025) Recent advances in immune regulation by targeting dendritic cells using small interfering RNAs. Curr Mol Med 25(7):792\u2013809","journal-title":"Curr Mol Med"},{"issue":"1","key":"12286_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10616-024-00677-4","volume":"77","author":"N Hosseinkhani","year":"2025","unstructured":"Hosseinkhani N, Alipour S, Ghaffari Jolfayi A, Aghebati-Maleki L, Baghbani E, Alizadeh N et al (2025) Docetaxel treatment together with CTLA-4 knockdown enhances reduction of cell viability and amplifies apoptosis stimulation of MCF-7 breast cancer cells. Cytotechnology 77(1):19","journal-title":"Cytotechnology"},{"issue":"18","key":"12286_CR18","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","volume":"25","author":"BA Weaver","year":"2014","unstructured":"Weaver BA (2014) How Taxol\/paclitaxel kills cancer cells. Mol Biol Cell 25(18):2677\u20132681","journal-title":"Mol Biol Cell"},{"issue":"1","key":"12286_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0304-3835(98)00388-7","volume":"136","author":"S Gagandeep","year":"1999","unstructured":"Gagandeep S, Novikoff PM, Ott M, Gupta S (1999) Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines. Cancer Lett 136(1):109\u2013118","journal-title":"Cancer Lett"},{"key":"12286_CR20","doi-asserted-by":"crossref","unstructured":"Liu Y, Guo J, Shen K, Wang R, Chen C, Liao Z et al (2020) Paclitaxel suppresses hepatocellular carcinoma tumorigenesis through regulating Circ-BIRC6\/miR-877-5p\/YWHAZ axis. OncoTargets therapy. 13 :9377\u20139388","DOI":"10.2147\/OTT.S261700"},{"key":"12286_CR21","doi-asserted-by":"crossref","unstructured":"Anwanwan D, Singh SK, Singh S, Saikam V, Singh R (2020) Challenges in liver cancer and possible treatment approaches. Biochimica et biophysica acta (BBA)-Reviews on cancer. 1873(1):188314","DOI":"10.1016\/j.bbcan.2019.188314"},{"issue":"1","key":"12286_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12026-024-09572-8","volume":"73","author":"B Naseri","year":"2025","unstructured":"Naseri B, Alipour S, Masoumi J, Hatami-Sadr A, Vaysi E, Hemmat N et al (2025) RAD001-mediated mTOR targeting in human monocyte-derived dendritic cells shifts them toward an immunogenic phenotype. Immunol Res 73(1):21","journal-title":"Immunol Res"},{"issue":"4","key":"12286_CR23","first-page":"883","volume":"15","author":"S Alipour","year":"2025","unstructured":"Alipour S, Sohrabi S, Mardi A, Karamali N, Baghbani E, Khaze V et al (2025) Mebendazole-treated human monocyte-derived dendritic cells represent promoted immunogenic phenotype with augmented expression of inflammatory markers. Adv Pharm Bull 15(4):883\u2013890","journal-title":"Adv Pharm Bull"},{"issue":"9","key":"12286_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.5732\/cjc.012.10280","volume":"32","author":"W Guo","year":"2013","unstructured":"Guo W, Chen W, Yu W, Huang W, Deng W (2013) Small interfering RNA-based molecular therapy of cancers. Chin J cancer 32(9):488","journal-title":"Chin J cancer"},{"issue":"1","key":"12286_CR25","doi-asserted-by":"publisher","first-page":"18122","DOI":"10.1038\/s41598-019-54731-9","volume":"9","author":"H Zhou","year":"2019","unstructured":"Zhou H, Dong J, Guo L, Wang X, Wang K, Cai X et al (2019) The prognostic value of B7-H6 in esophageal squamous cell carcinoma. Sci Rep 9(1):18122","journal-title":"Sci Rep"},{"key":"12286_CR26","doi-asserted-by":"publisher","first-page":"814312","DOI":"10.3389\/fonc.2022.814312","volume":"12","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Teng K-Y, Zhou J, Xu Y, Zhang L, Zhao H et al (2022) B7H6 serves as a negative prognostic marker and an immune modulator in human pancreatic cancer. Front Oncol 12:814312","journal-title":"Front Oncol"},{"issue":"23","key":"12286_CR27","doi-asserted-by":"publisher","first-page":"37435","DOI":"10.18632\/oncotarget.16391","volume":"8","author":"T Jiang","year":"2017","unstructured":"Jiang T, Wu W, Zhang H, Zhang X, Zhang D, Wang Q et al (2017) High expression of B7-H6 in human glioma tissues promotes tumor progression. Oncotarget 8(23):37435","journal-title":"Oncotarget"},{"issue":"4","key":"12286_CR28","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3892\/ijo.2016.3393","volume":"48","author":"F Wu","year":"2016","unstructured":"Wu F, Wang J, Ke X (2016) Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma. Int J Oncol 48(4):1561\u20131570","journal-title":"Int J Oncol"},{"issue":"1","key":"12286_CR29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s11033-024-10007-8","volume":"51","author":"S Safaei","year":"2024","unstructured":"Safaei S, Alipour S, Bahojb Mahdavi SZ, Shalmashi H, Shahgoli VK, Shanehbandi D et al (2024) Triple-negative breast cancer-derived exosomes change the immunological features of human monocyte-derived dendritic cells and influence T-cell responses. Mol Biol Rep 51(1):1058","journal-title":"Mol Biol Rep"},{"issue":"1","key":"12286_CR30","first-page":"91","volume":"16","author":"B Zhang","year":"2018","unstructured":"Zhang B, Sun J, Yao X, Li J, Tu Y, Yao F et al (2018) Knockdown of B7H6 inhibits tumor progression in triple\u2013negative breast cancer. Oncol Lett 16(1):91\u201396","journal-title":"Oncol Lett"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12286-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:10:04Z","timestamp":1783516204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12286-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12286"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12286-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1115"}}